Gynecologic Cancer Screening and Prevention: State of the Science and Practice.

Area of Science:

• Gynecology
• Oncology
• Preventive Medicine

Background:

• Gynecological cancers show rising global incidence and mortality.
• Advances in treatment have improved patient quality of life.
• Prevention strategies are a growing focus in gynecologic oncology.

Purpose of the Study:

• To review the current state of screening and prevention for gynecological cancers.
• To discuss recent advancements and pilot studies in the field.
• To highlight the disparities in screening effectiveness across different gynecologic cancer types.

Main Methods:

• Literature review of screening and prevention strategies for cervical, endometrial, ovarian, and vulvovaginal cancers.
• Analysis of current clinical practices and emerging research.
• Discussion of vaccination, cytology, HPV testing, genetic screening, and novel diagnostic modalities.

Main Results:

• Cervical cancer is the only preventable gynecologic cancer with established screening (cytology, HPV testing) and vaccination programs.
• Endometrial cancer detection is aided by symptoms, but asymptomatic screening is limited to high-risk groups.
• Ovarian cancer diagnosis is often late due to vague symptoms; research focuses on genetic screening and new modalities like liquid biopsies.

Conclusions:

• Effective screening and prevention are well-established for cervical cancer.
• Significant gaps exist in screening and prevention for other gynecologic cancers, particularly ovarian cancer.
• Ongoing research into novel screening technologies and genetic programs is crucial for improving outcomes in all gynecologic cancers.